Clinical Trial Detail

NCT ID NCT01846611
Title A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer


Pegylated liposomal-doxorubicin


Age Groups: adult

No variant requirements are available.